Celine practices general corporate and securities law, with an emphasis on the representation of emerging companies, venture capital funds and public companies. Celine represents her clients throughout the business life cycle in matters such as venture financings, mergers & acquisitions, public offerings, and Securities and Exchange Commission reporting and compliance.
Blue Owl Capital Invests up to $1.05 Billion in BridgeBio Pharma
January 17, 2024
Cooley advised Blue Owl Capital, a top asset manager redefining alternatives, on its strategic investment a $300 million royalty financing and a $450 million credit facility in BridgeBio Pharma, a commercial-stage biopharmaceutical company focused on genetic diseases and cancers.